Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Manion

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|May 19, 1997
Combination chemotherapy for human immunodeficiency virus-1D J Manion, M S Hirsch
The Journal of Infectious Diseases|July 1, 1997
Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitroD P Merrill, D J Manion, T C Chou, et al.
Antiviral Therapy|December 1, 1996
Susceptibility of human cytomegalovirus to two-drug combinations in vitroD J Manion, A Vibhagool, T C Chou, et al.
Archives of Virology|January 1, 1995
HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretorsM Margalith, R T D'Aquila, D J Manion, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|January 3, 2001
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trialD W Haas, W J Fessel, R A Delapenha, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|May 19, 1997
Combination chemotherapy for human immunodeficiency virus-1D J Manion, M S Hirsch
The Journal of Infectious Diseases|July 1, 1997
Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitroD P Merrill, D J Manion, T C Chou, et al.
Antiviral Therapy|December 1, 1996
Susceptibility of human cytomegalovirus to two-drug combinations in vitroD J Manion, A Vibhagool, T C Chou, et al.
Archives of Virology|January 1, 1995
HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretorsM Margalith, R T D'Aquila, D J Manion, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|January 3, 2001
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trialD W Haas, W J Fessel, R A Delapenha, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
Pageof 1